The application of water-dispersible hesperetin to the retina as a drug which improves retinal circulation

The application of water-dispersible hesperetin to the retina as a drug which improves retinal circulation - Water-disopersible hesperetin in the retinal diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012474

Enrollment

Registered

2013-12-10

Start date

2013-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy

Interventions

The administration of 200mg of water-dispersible hesperetin for 7 days

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Men who don't have any past history of diseases Older than or equal to 20 years old and younger than or equal 30 to years old. Subject who provide us informed consent after they make comprehension of the purpose of this study.

Exclusion criteria

Exclusion criteria: Subjects who take a medicine Subjects who have past history of eye diseases Subjects who smoke more than 20 cigarettes Subjects who are alcoholic

Design outcomes

Primary

Measure	Time frame
The change in the diameter, velocity and blood flow of retinal vessels	—

Countries

Japan

Contacts

Public ContactHarumasa Yokota

Asahikawa Medical University Department of Ophthalmology

atokoy18@asahikawa-med.ac.jp0166-68-2543

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026